Leon O Moulder Jr has bought stock on 12 days since Mar 2018

Leon O. Moulder, Jr. (age 67) is the Founder, Chief Executive Officer since August 2023, and Chairman of the Board since 2020 at Zenas BioPharma, Inc. (NASDAQ: ZBIO), a biopharmaceutical company focused on autoimmune diseases.( He holds a Pharmacy degree from Temple University and an MBA from the University of Chicago Booth School of Business.( Moulder began his career as a clinical pharmacist, followed by a 17-year tenure at predecessor companies of Sanofi, including Marion Laboratories, building commercial and operational expertise.(

Moulder's career highlights include serving as President and CEO of MGI PHARMA (later acquired by Eisai), President, CEO, and Vice Chairman of Abraxis BioScience, and co-founding TESARO, Inc., where he led as CEO from 2010 until its $5.5 billion acquisition by GSK in 2019.( Since March 2019, he has been Managing Member of Tellus BioVentures, LLC, with board roles at Zai Lab Ltd., Dianthus Therapeutics, and others.( Recently, as ZBIO CEO, he purchased $1.639 million in company stock (100,000 shares) between January 7-9, 2026, increasing his direct ownership to 366,155 shares.(

Written by Perplexity from public sources.